DR. MILAN FIALA, MD
Osteopathic Medicine at Ucla Medical Plz, Los Angeles, CA
License number
California A23625
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
100 Ucla Medical Plz SUITE 220, Los Angeles, CA 90095
Phone
(310) 206-6392
(310) 825-2042 (Fax)
(310) 825-2042 (Fax)
Personal information
See more information about MILAN FIALA at radaris.comName
Address
Phone
2529 Angelo Dr, Los Angeles, CA 90077
Beverly Hills, CA
2529 Angelo Dr, Los Angeles, CA 90077
3012 Greentree Ct, Los Angeles, CA 90077
3409 Camino De La Cumbre, Sherman Oaks, CA 91423
Organization information
See more information about MILAN FIALA at bizstanding.comMilan Fiala MD
100 Ucla Medical Plz, Los Angeles, CA 90024
Industry:
Medical Doctor's Office, Nonclassifiable Establishments, Offices and Clinics of Medical Doctors, Nsk
Phone:
(310) 206-6392 (Phone)
Principal:
Milan Fiala (Principal)
Categories:
Infectious Disease Physicians & Surgeons
Professional information
Dr. Milan Fiala, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
UCLA Medical Center
100 Ucla Medical Plz SUITE 220, Los Angeles 90024
(310) 206-6392 (Phone)
100 Ucla Medical Plz SUITE 220, Los Angeles 90024
(310) 206-6392 (Phone)
Certifications:
Infectious Disease, 1982, Internal Medicine, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UCLA Medical Center
100 Ucla Medical Plz SUITE 220, Los Angeles 90024
Henry Mayo Newhall Memorial Hospital
23845 Mcbean Pkwy, Valencia 91355
Providence Holy Cross Medical Center
15031 Rinaldi St, Mission Hills 91345
100 Ucla Medical Plz SUITE 220, Los Angeles 90024
Henry Mayo Newhall Memorial Hospital
23845 Mcbean Pkwy, Valencia 91355
Providence Holy Cross Medical Center
15031 Rinaldi St, Mission Hills 91345
Education:
Medical School
Central Medical University / Faculty of Medicine
Mass Gen Hospital
Newton Wellesley Hospital
University Wa Med Center
Central Medical University / Faculty of Medicine
Mass Gen Hospital
Newton Wellesley Hospital
University Wa Med Center
Professor At Ucla
Position:
Professor at UCLA
Location:
Greater Los Angeles Area
Industry:
Medical Devices
Work:
UCLA
-
Professor
Milan Fiala, Los Angeles CA
Specialties:
Infectious Disease Specialist
Address:
100 Ucla Medical Plz, Los Angeles, CA 90024
Education:
University of Geneva, Faculty of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Milan Fiala, Los Angeles CA
Specialties:
Internal Medicine, Infectious Disease
Work:
California Pain Medicine Centers
100 Ucla Medical Plz, Los Angeles, CA 90024
100 Ucla Medical Plz, Los Angeles, CA 90024
Education:
Centre Medicine University (1959)
Use Of Biomarkers Of Alzheimer's Disease For Diagnostic Tests And Drug Screening
US Patent:
2009010, Apr 23, 2009
Filed:
Oct 19, 2007
Appl. No.:
11/875729
Inventors:
Milan Fiala - Los Angeles CA, US
Assignee:
MP Biomedicals LLC - Santa Ana CA
International Classification:
G01N 33/53, C12Q 1/02
US Classification:
435 78, 435 29
Abstract:
The invention relates to method of diagnosing Alzheimer's disease or detecting a predisposition to Alzheimer's disease including providing a test cell sample from a subject, exposing the test cell sample to labeled amyloid beta peptides, and determining the level of labeled amyloid beta peptides in the test cell sample, wherein lower levels of labeled amyloid beta peptides in the test cell sample compared to a control cell sample are indicative of Alzheimer's disease.
Diagnostic Methods And Genetic Markers For Alzheimer Disease
US Patent:
2009026, Oct 22, 2009
Filed:
Mar 19, 2009
Appl. No.:
12/407756
Inventors:
John R. Cashman - San Diego CA, US
Milan Fiala - Los Angeles CA, US
Milan Fiala - Los Angeles CA, US
International Classification:
A61K 35/14, A61K 31/12, C12Q 1/02, G01N 33/00, C07C 69/76, C07C 49/00, C12Q 1/48, A61P 25/28
US Classification:
424529, 514679, 435 29, 436 94, 560 55, 568308, 435 15
Abstract:
Disclosed are methods for identifying individuals suffering from a CNS disorder (including Alzheimer's Disease, behavioral disorders, and the like) that could be treated with a CNS drug with greater therapeutic efficacy and lower side effects and the compounds useful for such treatment. Also disclosed are methods for predicting the efficacy of a drug candidate for the treatment of a CNS disorder. The technology is also applicable to drug discovery for use in animal models of neurodegenerative diseases.